Future Retail [FRETAIL] vs Astal Laboratories [ASTALLTD] Detailed Stock Comparison

Future Retail
NSE
Loading...

Astal Laboratories
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Future Retail wins in 10 metrics, Astal Laboratories wins in 8 metrics, with 0 ties. Future Retail appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Future Retail | Astal Laboratories | Better |
---|---|---|---|
P/E Ratio (TTM) | -0.04 | 10.43 | Future Retail |
Price-to-Book Ratio | -0.10 | 2.29 | Future Retail |
Debt-to-Equity Ratio | -12.67 | 36.86 | Future Retail |
PEG Ratio | 0.00 | 0.44 | Future Retail |
EV/EBITDA | -5.22 | 7.41 | Future Retail |
Profit Margin (TTM) | -52.09% | 12.33% | Astal Laboratories |
Operating Margin (TTM) | -25.44% | 11.14% | Astal Laboratories |
EBITDA Margin (TTM) | N/A | 11.14% | N/A |
Return on Equity | -291.62% | 24.80% | Astal Laboratories |
Return on Assets (TTM) | -16.76% | 14.09% | Astal Laboratories |
Free Cash Flow (TTM) | $-1.87B | $-203.57M | Astal Laboratories |
1-Year Return | 0.00% | -20.22% | Future Retail |
Price-to-Sales Ratio (TTM) | 0.01 | 1.20 | Future Retail |
Enterprise Value | $154.83B | $956.14M | Future Retail |
EV/Revenue Ratio | 1.83 | 1.26 | Astal Laboratories |
Gross Profit Margin (TTM) | 17.63% | 15.24% | Future Retail |
Revenue per Share (TTM) | $156 | $77 | Future Retail |
Earnings per Share (Diluted) | $-65.16 | $8.07 | Astal Laboratories |
Beta (Stock Volatility) | 1.05 | -0.81 | Astal Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Future Retail vs Astal Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Future Retail | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Astal Laboratories | -1.35% | -2.32% | -14.09% | -0.17% | 3.37% | 5.58% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Future Retail | 0.00% | -39.20% | -98.31% | -98.51% | -98.51% | -98.51% |
Astal Laboratories | -20.22% | 84.29% | 84.29% | 84.29% | 84.29% | 84.29% |
Performance & Financial Health Analysis: Future Retail vs Astal Laboratories
Metric | FRETAIL | ASTALLTD |
---|---|---|
Market Information | ||
Market Cap | ₹1.24B | ₹906.62M |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 63,719 | 34,108 |
90 Day Avg. Volume | 21,240 | 37,950 |
Last Close | ₹2.28 | ₹83.04 |
52 Week Range | ₹2.28 - ₹2.28 | ₹66.72 - ₹131.70 |
% from 52W High | 0.00% | -36.95% |
All-Time High | ₹638.61 (Nov 20, 2017) | ₹131.70 (Sep 09, 2024) |
% from All-Time High | -99.64% | -36.95% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.87% | 0.91% |
Quarterly Earnings Growth | 0.87% | 0.24% |
Financial Health | ||
Profit Margin (TTM) | -0.52% | 0.12% |
Operating Margin (TTM) | -0.25% | 0.11% |
Return on Equity (TTM) | -2.92% | 0.25% |
Debt to Equity (MRQ) | -12.67 | 36.86 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹-22.51 | ₹36.75 |
Cash per Share (MRQ) | ₹1.85 | ₹1.76 |
Operating Cash Flow (TTM) | ₹-3,108,300,000 | ₹-108,043,000 |
Levered Free Cash Flow (TTM) | ₹-31,895,200,000 | ₹89.25M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Future Retail vs Astal Laboratories
Metric | FRETAIL | ASTALLTD |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -0.04 | 10.43 |
Forward P/E | 0.12 | N/A |
PEG Ratio | 0.00 | 0.44 |
Price to Sales (TTM) | 0.01 | 1.20 |
Price to Book (MRQ) | -0.10 | 2.29 |
Market Capitalization | ||
Market Capitalization | ₹1.24B | ₹906.62M |
Enterprise Value | ₹154.83B | ₹956.14M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.83 | 1.26 |
Enterprise to EBITDA | -5.22 | 7.41 |
Risk & Other Metrics | ||
Beta | 1.05 | -0.81 |
Book Value per Share (MRQ) | ₹-22.51 | ₹36.75 |
Financial Statements Comparison: Future Retail vs Astal Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | FRETAIL | ASTALLTD |
---|---|---|
Revenue/Sales | ₹28.16B | ₹253.27M |
Cost of Goods Sold | ₹23.19B | ₹214.66M |
Gross Profit | ₹4.97B | ₹38.61M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹-7.30B | ₹30.38M |
EBITDA | ₹-3.10B | ₹32.14M |
Pre-Tax Income | ₹-10.63B | ₹27.93M |
Income Tax | N/A | ₹7.03M |
Net Income (Profit) | ₹-10.63B | ₹20.90M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | FRETAIL | ASTALLTD |
---|---|---|
Cash & Equivalents | ₹613.00M | ₹17.30M |
Total Current Assets | ₹97.76B | ₹456.39M |
Total Current Liabilities | ₹141.43B | ₹267.71M |
Long-Term Debt | ₹47.21B | ₹4.56M |
Total Shareholders Equity | ₹-12.21B | ₹359.95M |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹56.51B | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | FRETAIL | ASTALLTD |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | FRETAIL | ASTALLTD |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 63,719 | 34,108 |
Average Daily Volume (90 Day) | 21,240 | 37,950 |
Shares Outstanding | 542.28M | 9.83M |
Float Shares | 536.78M | 3.95M |
% Held by Insiders | 0.00% | 0.52% |
% Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Future Retail vs Astal Laboratories
Metric | FRETAIL | ASTALLTD |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |